MX2022012366A - Metodos para generar neuronas de dopamina del mesencefalo, neuronas del mesencefalo, y usos de las mismas. - Google Patents

Metodos para generar neuronas de dopamina del mesencefalo, neuronas del mesencefalo, y usos de las mismas.

Info

Publication number
MX2022012366A
MX2022012366A MX2022012366A MX2022012366A MX2022012366A MX 2022012366 A MX2022012366 A MX 2022012366A MX 2022012366 A MX2022012366 A MX 2022012366A MX 2022012366 A MX2022012366 A MX 2022012366A MX 2022012366 A MX2022012366 A MX 2022012366A
Authority
MX
Mexico
Prior art keywords
midbrain
neurons
methods
generating
dopamine neurons
Prior art date
Application number
MX2022012366A
Other languages
English (en)
Inventor
Lorenz Studer
Tae- Wan Kim
So- Yeon KOO
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Publication of MX2022012366A publication Critical patent/MX2022012366A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente divulgación proporciona métodos para generar neuronas de dopamina del mesencéfalo y precursores de las mismas, neuronas de dopamina del mesencéfalo y precursores de las mismas generadas mediante tales métodos y composiciones que comprenden tales células y usos de las mismas para prevenir, modelar, y/o tratar un trastorno neurológico.
MX2022012366A 2020-04-02 2021-04-02 Metodos para generar neuronas de dopamina del mesencefalo, neuronas del mesencefalo, y usos de las mismas. MX2022012366A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063004138P 2020-04-02 2020-04-02
PCT/US2021/025596 WO2021203009A1 (en) 2020-04-02 2021-04-02 Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof

Publications (1)

Publication Number Publication Date
MX2022012366A true MX2022012366A (es) 2022-12-15

Family

ID=77929755

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022012366A MX2022012366A (es) 2020-04-02 2021-04-02 Metodos para generar neuronas de dopamina del mesencefalo, neuronas del mesencefalo, y usos de las mismas.

Country Status (12)

Country Link
US (1) US20230143486A1 (es)
EP (1) EP4127137A4 (es)
JP (1) JP2023520466A (es)
KR (1) KR20220164012A (es)
CN (1) CN115768875A (es)
AU (1) AU2021248640A1 (es)
BR (1) BR112022019881A2 (es)
CA (1) CA3177525A1 (es)
IL (1) IL296919A (es)
MX (1) MX2022012366A (es)
WO (1) WO2021203009A1 (es)
ZA (1) ZA202211266B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023220639A2 (en) * 2022-05-10 2023-11-16 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for improved memory in the aging

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL295556A (en) * 2011-11-04 2022-10-01 Memorial Sloan Kettering Cancer Center Dopamine neurons from the midbrain for transplantation
EP3498824A1 (en) * 2013-04-26 2019-06-19 Memorial Sloan-Kettering Cancer Center Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells

Also Published As

Publication number Publication date
IL296919A (en) 2022-12-01
EP4127137A1 (en) 2023-02-08
KR20220164012A (ko) 2022-12-12
BR112022019881A2 (pt) 2022-11-22
ZA202211266B (en) 2023-05-31
JP2023520466A (ja) 2023-05-17
EP4127137A4 (en) 2024-05-22
CA3177525A1 (en) 2021-10-07
US20230143486A1 (en) 2023-05-11
CN115768875A (zh) 2023-03-07
AU2021248640A1 (en) 2022-10-27
WO2021203009A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
MX2021010193A (es) Azepino-indoles y otros heterociclos para el tratamiento de trastornos cerebrales.
MX2021010198A (es) Indoles n-sustituidos y otros heterociclos para el tratamiento de trastornos cerebrales.
MX2023012245A (es) Compuestos, composiciones y metodos para el tratamiento del cancer.
WO2017204445A3 (ko) Alk 단백질의 분해를 유도하는 약학적 조성물 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
PH12021550558A1 (en) Modulators of pnpla3 expression
MX2022002532A (es) Métodos para generar y aislar neuronas de dopamina del mesencéfalo.
CR20210395A (es) Moduladores de la expresión de hsd17b13
MX2019011506A (es) Inhibicion de cinasa 1 de punto de control (chk1) para el tratamiento de cancer.
ZA202207804B (en) Compounds and uses thereof
MX2018006309A (es) Particulas recubiertas y metodos de fabricacion y uso de las mismas.
MX2022008395A (es) Inhibidores de sarm1.
MX2019000980A (es) Compuestos y composiciones y usos de los mismos.
PH12020551995A1 (en) Modulator of apol1 expression
MX2023002256A (es) Inhibidores de sarm1.
PH12019502174A1 (en) Modulators of pcsk9 expression
MX2022009369A (es) Compuestos y usos de estos.
PH12021551053A1 (en) Modulators of irf5 expression
MX2020009147A (es) Moduladores de la expresion de irf4.
MX2022009366A (es) Compuestos y usos de estos.
MX2022009367A (es) Compuestos y usos de estos.
MX2022012366A (es) Metodos para generar neuronas de dopamina del mesencefalo, neuronas del mesencefalo, y usos de las mismas.
MX2024001243A (es) Composiciones y metodos para el tratamiento de melanoma.
MX2022000811A (es) Inhibidores de enzimas.
MX2023009059A (es) Antagonistas de gpr84 y usos de estos.
MX2020010721A (es) Moduladores de la expresion de ezh2.